CN

CN
Project
MOA
Diseases
Target
Validation
Lead
Compound
Candidate
IND
Clinical Trial
Commercial
  • IPG11406
    GPR183(EBI2)Small molecule Antagonist
    · Autoimmune diseases : MS , IBD , RA , SLE
    Global
  • IPG1094
    MIF Small molecule Inhibitor
    · Cancer : Solid tumor , multiple myeloma
    · Autoimmune diseases : SLE , psoriasis , MS
    Global
  • IPG7236
    CCR8 Small molecule Antagonist
    · Cancer : Solid tumor
    · Autoimmune diseases : IgG4-related diseases
    Global
  • IPG8294
    CD38 Small molecule Inhibitor
    · Neurodegenerative diseases : AD
    · Mitochondrial myopathy
    Global
  • IPG0521
    CCR8 Antagonist mAb
    · Cancer : Solid tumor
    Global
  • IPG6620
    Undisclosed
    · CIPN
    Global
  • IPGA09
    Undisclosed
    · Autoimmune diseases
    Global
  • IPGA06
    Undisclosed
    · Cancer
    Global
  • IPGA17
    Undisclosed
    · Cancer
    Global
  • IPG017
    Undisclosed
    · Autoimmune diseases
    Global
  • IPG023
    Undisclosed
    · Autoimmune diseases
    Global
  • IPGA12
    Undisclosed
    · Autoimmune diseases
    Global
Project
Type
Diseases
Target
Validation
Lead
compound
Candidate
INDfilling
Phase 1-3
clinical trial
Commercial
  • IPG11406
    GPR183(EBI2)Small molecule Antagonist
    · Autoimmune diseases : MS , IBD , RA , SLE
    Global
  • IPG1094
    MIF Small molecule Inhibitor
    · Cancer : Solid tumor , multiple myeloma
    · Autoimmune diseases : SLE , psoriasis , MS
    Global
  • IPG7236
    CCR8 Small molecule Antagonist
    · Cancer : Solid tumor
    · Autoimmune diseases : IgG4-related diseases
    Global
  • IPG8294
    CD38 Small molecule Inhibitor
    · Neurodegenerative diseases : AD
    · Mitochondrial myopathy
    Global
  • IPG0521
    CCR8 Antagonist mAb
    · Cancer : Solid tumor
    Global
  • IPG6620
    Undisclosed
    · CIPN
    Global
  • IPGA09
    Undisclosed
    · Autoimmune diseases
    Global
  • IPGA06
    Undisclosed
    · Cancer
    Global
  • IPGA17
    Undisclosed
    · Cancer
    Global
  • IPG017
    Undisclosed
    · Autoimmune diseases
    Global
  • IPG023
    Undisclosed
    · Autoimmune diseases
    Global
  • IPGA12
    Undisclosed
    · Autoimmune diseases
    Global

Cpyright © 2023 Nanjing Immunophage Biotech Co.,Ltd All Rights Reserved.